Congratulations!!

Alok Khorana, MD Thejus Jayakrishnan Kimmie Ng, MD, MPH I wrote a thread previously on the nuances involved in interpreting the rising rates of early onset #PancreaticCancer. x.com/Aiims1742/stat…

Anirban Maitra Thejus Jayakrishnan Kimmie Ng, MD, MPH Thanks for sharing, agree completely. I would that we have previously shown that yes there is a rise in EO panc adenoca but it is actually *less* than the secular rise in pancreatic cancer (30% vs 111%)

Anirban Maitra Thejus Jayakrishnan Kimmie Ng, MD, MPH Link here: onlinelibrary.wiley.com/doi/10.1002/ca…

From JAMA: Early-onset gastrointestinal cancers are among the largest subset of early-onset cancers globally. This JAMA Review summarizes current evidence on early-onset gastrointestinal cancers. ja.ma/3GSXvOo Kimmie Ng, MD, MPH Dana-Farber

Young adults with cancer need top notch care—but they also need connection, community, and care that gets them. 💬🎧🧠🧘‍♂️ Join us (and the amazing Chris Cann, MD) as we build a program that heals mind, body & soul—without any crystal balls. Fox Chase Cancer Center

At #ASCO25, research emphasized exercise, diet, and timing of immunochemotherapy as key to improving colon cancer outcomes, and called for a focus on survival and quality of life in clinical trials. 🔗 Learn more in this Medical News article: ja.ma/3Up99Uj

Congrats Udhay!

HIMALAYA is the 1st phase III trial to show 5-year OS in unresectable HCC! regular Durva/single Tremelimumab (Stride) 5-yr OS 19.6% vs 9.4% w/ Sorafenib ✅ Durable benefit ✅ No new late toxicities 🔹Benefit seen regardless of RECIST response #LiverCancer #HCC #Immunotherapy

🟠1L treatments of advanced pancreatic cancer ➡️mFOLFIRINOX or S-IROX vs Gem-nab-paclitaxel GENERATE, JCOG1611 Journal of Clinical Oncology ❌mFOLFIRINOX is not superior to Gem-nabPacli ❌No difference in OS, PFS and ORR 👉ascopubs.org/doi/pdf/10.120… ASCO OncoAlert #cancer #oncology #pancreatic

Tas Kapetanos MD Thejus Jayakrishnan Jay Bruce Hard cosign ✍️

Haha thanks Dr. Tas Kapetanos MD ! Hope you enjoyed the card and thanks Jay Bruce for the personal delivery! :)

Recorded a small talk for VuMedi Oncology on early onset colon cancer 🔗 vumedi.com/video/comparin… Key points I covered: 🔹 evolving trends in early (<50) and very early onset (<40) colon cancer 🔹 Stage-wise survival differences 🔹 Implications for screening and awareness

My first Pan-Mass Challenge ride in books! Proud to ride alongside so many who are tackling cancer in different ways. Honored to represent Dana-Farber's Young-Onset Colorectal Cancer Center Kimmie Ng, MD, MPH

Link to continue supporting my ride and research at Dana-Farber's Young-Onset Colorectal Cancer Center profile.pmc.org/TJ0141

Finally published The Oncologist: "Blueprint for creating an #earlyonset #colorectal #cancer program based on experiences from seven clinical centers across the United States and Canada" academic.oup.com/oncolo/article… #earlyonset #colorectal #cancer #cancerresearch Vanderbilt University Medical Center

#PMC2025 Pan-Mass Challenge

Grateful to The New York Times for speaking with me about diet & lifestyle and colorectal cancer risk Dana-Farber's Young-Onset Colorectal Cancer Center Dana-Farber News Dana-Farber 👇 nytimes.com/2025/08/02/wel…

.Kiran Turaga joins Eric Winer, MD tonight at 7:30pm for #appendixcancerawarenessmonth. Dr. Turaga explains how surgeons identify and treat appendix cancer, and discusses research that shows an ⬆️ in young adult cases. 🔸 Listen live Connecticut Public 🔸 Download Apple Podcasts 🔸 Watch YouTube

Early-Onset Gastrointestinal Cancers buff.ly/6TJk3cu Early-onset gastrointestinal (GI) cancers—diagnosed in individuals under 50—are rising globally and represent the fastest-growing group of early-onset cancers in the U.S., with colorectal cancer (CRC) being the most